TAVO412
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for TAVO412, covering 2024-10-23 to 2025-01-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAVO412 in Patients with Cancer (TAVO412) [Phase 1]